Literature DB >> 2222977

Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation.

G de Simone1, D C Wallerson, M Volpe, R B Devereux.   

Abstract

Although rats are commonly used to study left ventricular (LV) hypertrophy, measurement of LV mass and dimensions has required killing the rat. To determine the accuracy of echocardiography in rats, blinded crossectional area (CSA) and LV mass measurements using either the cube function (LVM) or an elliptical model (LVMel) from high resolution M-mode echocardiograms were compared to necropsy LV weight (0.28 to 1.5 g), in 41 normotensive (body weight 116 to 762 g) and 17 hypertensive rats (350 to 560 g). Postmortem chamber volumes in 28 normal rats (0.02 to 0.19 mL) were also compared to echocardiographic volumes derived from the elliptical model. Correlation with LV weight was r = 0.87 for LVM, 0.90 for CSA and 0.93 for LVMel (all P less than .00001). Comparison of hypertensive and body-weight-matched normotensive rats revealed the upper normal limit for both LVMel and CSA to have 89% sensitivity and 100% specificity for detection of post mortem LV hypertrophy. Necropsy LV volumes were more closely related to systolic echocardiographic volumes than to diastolic volumes (r = 0.78 v 0.71, both P less than .00001), compatible with the effects of post mortem contracture. Stroke volume determined invasively in 5 Wistar rats by thermodilution was similar to that obtained using elliptical model echo volumes in 5 rats of the same body size (0.35 +/- 0.05 v 0.30 +/- 0.06 mL/beat). Echocardiography can be used to evaluate LV structure and function in rats and to detect in vivo LV anatomic differences induced by hypertension.

Entities:  

Mesh:

Year:  1990        PMID: 2222977     DOI: 10.1093/ajh/3.9.688

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  18 in total

1.  Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.

Authors:  David Benoist; Rachel Stones; Mark J Drinkhill; Alan P Benson; Zhaokang Yang; Cecile Cassan; Stephen H Gilbert; David A Saint; Olivier Cazorla; Derek S Steele; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

2.  New Echocardiographic Protocol for the Assessment of Experimental Myocardial Infarction in Rats.

Authors:  Ruxandra Dragoi Galrinho; Andrea Olivia Ciobanu; Roxana Cristina Rimbas; Catalin Gabriel Manole; Bogdan Marinescu Leena; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2015-06

3.  Age-related changes in familial hypertrophic cardiomyopathy phenotype in transgenic mice and humans.

Authors:  Hong-Chang Luo; Iraklis Pozios; Styliani Vakrou; Lars Sorensen; Roselle M Abraham; Theodore Abraham
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

4.  Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.

Authors:  Srikanth Givvimani; Natia Qipshidze; Neetu Tyagi; Paras K Mishra; Utpal Sen; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-05-29

5.  Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response.

Authors:  Rajesh Katare; Andrea Caporali; Costanza Emanueli; Paolo Madeddu
Journal:  J Mol Cell Cardiol       Date:  2010-06-08       Impact factor: 5.000

6.  Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy.

Authors:  Fatih Yalçin; Nagehan Kucukler; Oscar Cingolani; Blaid Mbiyangandu; Lars Sorensen; Aurelio Pinherio; M Roselle Abraham; Theodore P Abraham
Journal:  J Appl Physiol (1985)       Date:  2018-01-04

7.  Rapid quantification of myocardial fibrosis: a new macro-based automated analysis.

Authors:  Awal M Hadi; Koen T B Mouchaers; Ingrid Schalij; Katrien Grunberg; Gerrit A Meijer; Anton Vonk-Noordegraaf; Willem J van der Laarse; Jeroen A M Beliën
Journal:  Cell Oncol (Dordr)       Date:  2011-05-03       Impact factor: 6.730

8.  Myostatin does not regulate cardiac hypertrophy or fibrosis.

Authors:  Ronald D Cohn; Hsin-Yueh Liang; Reena Shetty; Theodore Abraham; Kathryn R Wagner
Journal:  Neuromuscul Disord       Date:  2007-03-02       Impact factor: 4.296

9.  Increased susceptibility of spontaneously hypertensive rats to ventricular tachyarrhythmias in early hypertension.

Authors:  Thao P Nguyen; Ali A Sovari; Arash Pezhouman; Shankar Iyer; Hong Cao; Christopher Y Ko; Aneesh Bapat; Nooshin Vahdani; Mostafa Ghanim; Michael C Fishbein; Hrayr S Karagueuzian
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

10.  Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.

Authors:  Theodore P Abraham; Michelle Jones; Katarzyna Kazmierczak; Hsin-Yueh Liang; Aurelio C Pinheiro; Cory S Wagg; Gary D Lopaschuk; Danuta Szczesna-Cordary
Journal:  Cardiovasc Res       Date:  2009-01-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.